August 19th 2025
Altimmune's pemvidutide gains FDA Fast Track designation for alcohol use disorder.
Adolescent Substance Use: Reasons for Optimism and Concern
July 19th 2023"Although adolescent substance use is a topic that can be challenging for families and clinicians alike, data demonstrate that interventions during this time are effective for preventing, identifying, and reducing risky use."
Read More